Literature DB >> 18561583

Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne.

Emil Tanghetti1, Leon Kircik, David Wilson, Sunil Dhawan.   

Abstract

BACKGROUND: Benzoyl peroxide (BPO) is poorly soluble. A solubilized formulation of BPO has been developed to maximize its bioavailability and enhance follicular penetration.
METHODS: Patients with acne vulgaris were randomly assigned to receive solubilized BPO 5% gel on one side of the face and a BPO 5%/clindamycin 1% combination product on the contralateral side, twice daily for 4 weeks.
RESULTS: Of 23 patients enrolled, 100% completed the study. Reductions in lesion count with the solubilized BPO gel were at least as great as with BPO/clindamycin--and significantly greater (P< or =.05) for noninflammatory lesions at week 1 and inflammatory lesions at week 4. Both regimens were generally well tolerated and patient satisfaction was comparable.
CONCLUSIONS: Solubilized BPO 5% gel monotherapy offers significantly greater efficacy, and comparable patient satisfaction, compared with BPO/clindamycin. The early reduction in lesion counts observed with the solubilized BPO gel in the absence of an antibiotic is clinically relevant.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18561583

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  4 in total

1.  A Three-Step Acne System Containing Solubilized Benzoyl Peroxide versus Benzoyl Peroxide/Clindamycin in Pediatric Patients with Acne.

Authors:  Lawrence F Eichenfield; Diane Thiboutot; Alan Shalita; Leonard Swinyer; Emil Tanghetti; Eduardo Tschen; Lisa Parr
Journal:  J Clin Aesthet Dermatol       Date:  2009-11

2.  Efficacy and Tolerability of a Three-Step Acne System Containing a Solubilized Benzoyl Peroxide Lotion versus a Benzoyl Peroxide/Clindamycin Combination Product: An Investigator-Blind, Randomized, Parallel-Group Study.

Authors:  Lawrence J Green; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2008-09

3.  Problems in the reporting of acne clinical trials: a spot check from the 2009 Annual Evidence Update on Acne Vulgaris.

Authors:  John R Ingram; Douglas J C Grindlay; Hywel C Williams
Journal:  Trials       Date:  2010-07-12       Impact factor: 2.279

4.  Topical benzoyl peroxide for acne.

Authors:  Zhirong Yang; Yuan Zhang; Elvira Lazic Mosler; Jing Hu; Hang Li; Yanchang Zhang; Jia Liu; Qian Zhang
Journal:  Cochrane Database Syst Rev       Date:  2020-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.